Synthesis and antibacterial activities of novel 4-hydroxy-7-hydroxy- and 3-carboxycoumarin derivatives

Molecules

Volumn 17, Issue 9, 2012, Pages 10846-10863

  Lin, Pen Yuan ^a   Yeh, Kuang Sheng ^b   Su, Chien Ling ^a   Sheu, Shiow Yunn ^a   Chen, Tiffany ^c   Ou, Keng Liang ^a   Lin, Mei Hsiang ^a   Lee, Lin Wen ^d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b School of Veterinary Medicine   (Taiwan)

^c UNIVERSITY OF WASHINGTON   (United States)

^d School of Medicine   (Taiwan)

Author keywords

3 carboxycoumarin derivatives; 4 hydroxy ; 7 hydroxy ; Antibacterial activities

Indexed keywords

4 HYDROXYCOUMARIN; 4 HYDROXYCOUMARIN DERIVATIVE; 4-HYDROXYCOUMARIN; 7-HYDROXYCOUMARIN; ANTIINFECTIVE AGENT; COUMARIN; COUMARIN DERIVATIVE; UMBELLIFERONE; UMBELLIFERONE DERIVATIVE;

ARTICLE; BACILLUS SUBTILIS; BACTERIUM; CHEMISTRY; DRUG EFFECT; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TEST; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

4-HYDROXYCOUMARINS; ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; BACTERIA; COUMARINS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP; UMBELLIFERONES;

EID: 84866939200     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules170910846     Document Type: Article

References (38)

1. Dastan, D.; Salehi, P.; Gohari, A.R.; Zimmermann, S.; Kaiser, M.; Hamburger, M.; Khavasi, H.R.; Ebrahimi, S.N. Disesquiterpene and sesquiterpene coumarins from Ferula pseudalliacea, and determination of their absolute configurations. Phytochemistry 2012, 78, 170-178.
2. Verma, P.; Pal, H. Intriguing H-aggregate and H-dimer formation of coumarin-481 dye in aqueous solution as evidenced from photophysical studies. J. Phys. Chem. A 2012, 116, 4473-4484.
3. Stoianov, S.V.; Robinson, H.D. Two-Photon Activated Two-Photon Fluorescence and Binding of Azidocoumarin in a Gelatin Matrix. J. Fluoresc. 2012, 22, 1291-1300.
4. Manevich, Y.; Held, K.D.; Biaglow, J.E. Coumarin-3-carboxylic acid as a detector for hydroxyl radicals generated chemically and by gamma radiation. Radiat. Res. 1997, 148, 580-591.
5. Xing, Z.; Fu, Y.; Zhou, J.; Zhu, C.; Cheng, Y. Coumarin-based chiral fluorescence sensor incorporating a thiourea unit for highly enantioselective recognition of N-Boc-protected proline. Org. Biomol. Chem. 2012, 10, 4024-4028.
6. Barooah, N.; Mohanty, J.; Pal, H.; Bhasikuttan, A.C. Non-covalent interactions of coumarin dyes with cucurbit[7]uril macrocycle: modulation of ICT to TICT state conversion. Org. Biomol. Chem. 2012, 10, 5055-5062.
7. Chung, J.W.; Lee, K.; Neikirk, C.; Nelson, C.M.; Priestley, R.D. Photoresponsive coumarinstabilized polymeric nanoparticles as a detectable drug carrier. Small 2012, 8, 1693-1700.
8. Li, H.; Xiao, Y.; Niu, J.; Chen, X.; Ping, Q. Preparation of a cationic nanoemulsome for intratumoral drug delivery and its enhancing effect on cellular uptake in vitro. J. Nanosci. Nanotechnol. 2011, 11, 8547-8555.
9. Dahl, O.E. New oral antithrombotics: Focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders. Vasc. Health Risk Manag. 2012, 8, 45-57.
10. Penning-Van Beest, F.J.; Koerselman, J.; Herings, R.M. Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants. J. Thromb. Haemost. 2008, 6, 284-290.
11. Kontogiorgis, C.; Hadjipavlou-Litina, D. Biological evaluation of several coumarin derivatives designed possible anti-inflammatory/antioxidant agents. J. Enzyme Inhib. Med. Chem. 2003, 18, 63-69.
12. Liu, Z.Q.; Yu, W.; Liu, Z.L. Antioxidative and prooxidative effects of coumarin derivatives on free radical initiated and photosensitized peroxidation of human low-density lipoprotein. Chem. Phys. Lipids 1999, 103, 125-135.
13. Hamdi, N.; Passarelli, V.; Romerosa, A. Synthesis, spectroscopy and electrochemistry of new 4-(4-acetyl-5-substituted-4,5-dihydro-1,3,4-oxadiazol-2- yl)methoxy)-2H-chromen-2-ones as a novel class of potential antibacterial and antioxidant derivatives. C. R. Chim. 2011, 14, 548-555.
14. Hamdi, N.; Bouabdallah, F.; Romerosa, A. Expedious synthesis for α, β unsaturated coumarin derivatives using boran chelates: A novel class of potential antibacterial and antioxidant agents. C. R. Chim. 2010, 13, 1261-1268.
15. Hamdi, N.; Fischmeister, C.; Puerta, M.C.; Valerga, P. A rapid access to new coumarinyl chalcone and substituted chromen[4,3-c] pyrazol-4(1H)-ones and their antibacterial and DPPH radical scavenging activities. Med. Chem. Res. 2011, 20, 522-530.
16. Finn, G.J.; Kenealy, E.; Creaven, B.S.; Egan, D.A. In vitro cytotoxic potential and mechanism of action of selected coumarins, using human renal cell lines. Cancer Lett. 2002, 183, 61-68.
17. Jimenez-Orozco, F.A.; Lopez-Gonzalez, J.S.; Nieto-Rodriguez, A. Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin. Lung Cancer 2001, 34, 185-194.
18. Weber, U.S.; Steffen, B.; Siegers, C.P. Antitumor-activities of coumarin, 7-hydroxy-coumarin and its glucuronide in several human tumor cell lines. Res. Commun. Mol. Pathol. Pharmacol. 1998, 99, 193-206.
19. Singh, R.K.; Lange, T.S.; Kim, K.K.; Brard, L. A coumarin derivatives (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells. Invest. New Drugs 2011, 29, 63-72.
20. Sabry, N.M.; Mohamed, H.M.; Khattab, E.S.; Motlaq, S.S.; El-Agrody, A.M. Synthesis of 4H-chromene, coumarin, 12H-chromeno[2,3-d]pyrimidine derivatives and some of their antimicrobial and cytotoxicity activities. Eur. J. Med. Chem. 2011, 46, 765-772.
21. Musa, M.A.; Badisa, V.L.; Latinwo, L.M.; Cooperwood, J.; Sinclari, A.; Abdullah, A. Cytotoxic activity of new acetoxycoummarin derivatives in cancer cell lines. Anticancer Res. 2011, 31, 2017-2022.
22. Bronikowska, J.; Szliszka, E.; Jaworska, D.; Czuba, Z.P.; Krol, W. The Coumarin Psoralidin Enhances Anticancer Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL). Molecules 2012, 17, 6449-6464.
23. Roma, G.; di Braccio, M.; Grossi, G.; Piras, D.; Leoncini, G.; Bruzzese, D.; Signorello, M.G.; Fossa, P.; Mosti, L. Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site. J. Med. Chem. 2007, 12, 2886-2895.
24. Dekić, B.R.; Radulović, N.S.; Dekić, V.S.; Vukićević, R.D.; Palić, R.M. Synthesis and antimicrobial activity of new 4-heteroarylamino coumarin derivatives containing nitrogen and sulfur as heteroatoms. Molecules 2010, 15, 2246-2256.
25. Chimenti, F.; Bizzarri, B.; Bolasco, A.; Secci, D.; Chimenti, P.; Granese, A.; Carradori, S.; Rivanera, D.; Zicari, A.; Scaltrito, M.M.; et al. Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides. Bioorg. Med. Chem. Lett. 2010, 20, 4922-4926.
26. Kulkarni, A.; Patil, S.A.; Badami, P.S. Synthesis, characterization, DNA cleavage and in vitro antimicrobial studies of La(III), Th(IV) and VO(IV) complexes with Schiff bases of coumarin derivatives. Eur. J. Med. Chem. 2009, 44, 2904-2912.
27. Zavrsnik, D.; Muratovic, S.; Spirtovic, S.; Softic, D.; Medic-Saric, M. The synthesis and antimicrobial activity of some 4-hydroxycoumarin derivatives. Bosn. J. Basic Med. Sci. 2008, 8, 277-281.
28. Siddiqui, Z.N.; Musthafa, T.N.M.; Ahmad, A.; Khan, A.U. Synthesis of 4-hydroxycoumarin heteroarylhybrids as potential antimicrobial agents. Arch. Pharm. (Weinheim) 2011, 344, 394-401.
29. Basanagouda, M.; Shivashankar, K.; Kulkarni, M.V.; Rasal, V.P.; Patel, H.; Mutha, S.S.; Mohite, A.A. Synthesis and antimicrobial studies on novel sulfonamides containing 4-azidomethyl coumarin. Eur. J. Med. Chem. 2010, 45, 1151-1157.
30. Rehman, S.U.; Chohan, Z.H.; Glunaz, F.; Supuran, C.T. In-vitro antibacterial, antifungal and cytotoxic activities of some coumarins and their metal complexes. J. Enzyme Inhib. Med. Chem. 2005, 20, 333-340.
31. Guo, Q.; Liu, M.L.; Feng, L.S.; Lv, K.; Guan, Y.; Guo, H.Y.; Xiao, C.L. Synthesis and in vitro antimycobacterial activity of fluoroquinolone derivatives containing a coumarin moiety. Arch. Pharm. (Weinheim) 2011, 344, 802-809.
32. Chiang, C.C.; Cheng, M.J.; Peng, C.F.; Huang, H.Y.; Chen, I.S. A novel dimeric coumarin analog and antimycobacterial constituents from Fatoua pilosa. Chem. Biodivers. 2010, 7, 1728-1736.
33. Upadhyay, K.; Bavishi, A.; Thakrar, S.; Radadiya, A.; Vala, H.; Parekh, S.; Bhavsar, D.; Savant, M.; Parmar, M.; Adlakha, P.; et al. Synthesis and biological evaluation of 4-styrylcoumarin derivatives as inhibitors of TNF-α and IL-6 with anti-tubercular activity. Bioorg. Med. Chem. Lett. 2011, 21, 2547-2549.
34. Kampranis, S.C.; Gormley, N.A.; Tranter, R.; Orphanides, G.; Maxwell, A. Probing of Coumarins and Cyclothialidines to DNA Gyrase. Biochemistry 1999, 38, 1967-1976.
35. Wang, H.X.; Ng, T.B. Examination of lectins, polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus reverse transcriptase and glycohydrolases. Planta Med. 2001, 67, 669-672.
36. Maoa, P.C.; Mouscadet, J.F.; Leh, H.; Auclair, C.; Hsu, L.Y. Chemical modification of coumarin dimmer and HIV-1 integrase inhibitory activity. Chem. Pharm. Bull. 2002, 50, 1634-1637.
37. Le, B.G.; Radanyi, C.; Peyrat, J.F.; Brion, J.D.; Alami, M.; Marsaud, V.; Stella, B.; Renoir, J.M. New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein90. J. Med. Chem. 2007, 50, 6189-6200.
38. Lin, L.H.; Lee, L.W.; Sheu, S.Y.; Lin, P.Y. Study on the stevioside analogues of steviolbioside, steviol, and isosteviol 19-alkyl amide dimers: synthesis and cytotoxic and antibacterial activity. Chem. Pharm. Bull. 2004, 52, 1117-1122.